Form D · Biotechnology
MSDX, Inc.
Tucson, AZ · CIK 0001505022
Offering snapshot reported Feb 26, 2014 · SEC filing
- Reported sold
- $0 Offering amount: $750K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 18, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 26, 2014 | Initial | $0 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-212517
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Feb 26, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Bassett | Director |
| Allan Conger | Director |
| Rick Gibson | Director, Executive |
| Simranjeet Nirh | Director, Executive |
| Marie Wesselhoft | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9040 S. Rita Rd. #1100
Tucson, AZ, 85747
Tucson, AZ, 85747